LIPID PROFILE AND ANTIOXIDANT ASSESSMENT OF CAFFEINE INDUCED ALBINO RATS TREATED WITH NIFEDIPINE
Fatai A. Kareem, Ademola O. Akinyemi, Anuoluwapo O. Ajayi & Naomi A. Folorunsho , August 2022, Published: 2022-08-28
Hypertension is a chronic elevation of blood pressure that, in the long-term results in increased morbidity and
mortality. The present study investigates the effectiveness of 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-
dihydropyridine-3,5-dicarboxylate (nifedipine) on lipid profile and antioxidant level of caffeine induced hypertensive
albino rats. Twenty-one adult albino rats weighing between 100 and 200g were grouped into three consisting of
seven animals each. The control group were fed and orally administered with normal saline, the model and treatment
groups were fed and given body weight 100 mg/Kg of caffeine orally for three days while the treatment group was
administered with 2ml/kg body weight of nifedipine orally for three days. The blood pressure and body weight were
measured accordingly. The animals were sacrificed twenty-four (24) hours after the last administration. The blood
sample was collected for assay. There was increase in body weight and blood pressure of the model group when
compared with the control while it was restored in the treatment group. The results revealed an increase in total
cholesterol and low density lipoprotein level in the model group and restoration in the treatment group. The
atherogenic index of the plasma, Castelli’s risk index I and II and atherogenic coefficient were increased in the
model group while it was restored in the treatment group. There was reduced antioxidants level in the model group
and the antioxidants were restored in the treatment group. This study confirmed the antihypertensive potential of
nifedipine and therefore can be used as a strong therapy for hypertension with minimum side effects.
Keywords: Antioxidant, blood pressure, calcium-channel blocker, hypertension and lipid profile


